Heart MRI breakthrough: new scan could replace needle biopsy for rare heart disease
NCT ID NCT04862273
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a special type of heart MRI, called T1 mapping, can accurately diagnose cardiac amyloidosis—a condition where abnormal proteins build up in the heart muscle. Researchers studied 112 older adults with heart failure and thickened heart walls. They compared the MRI results to standard tests like a heart biopsy or a special scan. If T1 mapping proves reliable, it could offer a safer, non-invasive way to diagnose this serious condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Native T1 cardiac magnetic resonance imaging (CMR)
What this could lead to
If successful, this MRI technique could become a faster, non-invasive way to diagnose cardiac amyloidosis, reducing the need for biopsies.
What could go wrong
This is a completed study with 112 participants, so results are preliminary. The technique may not be as accurate as standard methods in all patients, and its usefulness depends on further validation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Leipzig
Leipzig, Saxony, 04103, Germany